RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

DNA Funded vs TopTier Trader

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

DNAF

DNA Funded

TTTR

TopTier Trader

EST. 2021

DNA FUNDED

METRIC

TOPTIER TRADER

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

80%

—

MAX FUNDING

$300,000

—

MIN COST

$65

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

DNA FUNDED DETAILS

STEPS: -phase

TOPTIER TRADER DETAILS

STEPS: 1-phase
DRAWDOWN: Fixed
MARKETS: Forex
PLATFORMS: MT5, MatchTrader, A-Trader

DNA Funded PROS

+No performance data is available to identify any above-average metrics for this firm
+No fee, payout, or structure data provided to evaluate competitiveness
+No platform or market data available to assess trading flexibility
+Country of operation (Australia) is noted, but no regulatory or structural data exists

DNA Funded CONS

−No data is provided for this firm, making any meaningful comparison impossible
−Traders cannot assess profit split, funding, or costs against the 84.7% and $186.7 averages
−Complete absence of data is a significant transparency concern for traders making financial decisions

TopTier Trader PROS

+Days to first payout of 1 is exceptional, far below the industry average of 6.5 days
+Min challenge cost of $65 is well below the industry average of $186.7, reducing entry cost
+Single-step funding process beats the industry average of 1.6 steps for faster capital access
+On-demand payout frequency offers maximum withdrawal flexibility for funded traders

TopTier Trader CONS

−Profit split of 80% is below the industry average of 84.7%, reducing trader earnings
−Overall drawdown of 5% is meaningfully below the industry average of 7.9%, offering less buffer
−Max funding of $300,000 is significantly below the industry average of $839,272.7

PROPDNA VERDICT

DNA Funded

Higher trust score (0/100). Slower payouts at —d.

START WITH DNAF